Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 LYSOSTAPHIN: ENZYMATIC MODE OF ACTION.

× No keyword cloud information.

86 in total

1. Purification and partial characterization of a murein hydrolase, millericin B, produced by Streptococcus milleri NMSCC 061.

Authors: M Beukes; G Bierbaum; H G Sahl; J W Hastings
Journal: Appl Environ Microbiol Date: 2000-01 Impact factor: 4.792

2. ABI domain-containing proteins contribute to surface protein display and cell division in Staphylococcus aureus.

Authors: Matthew B Frankel; Brandon M Wojcik; Andrea C DeDent; Dominique M Missiakas; Olaf Schneewind
Journal: Mol Microbiol Date: 2010-10 Impact factor: 3.501

3. Inhibition of the activity of both domains of lysostaphin through peptidoglycan modification by the lysostaphin immunity protein.

Authors: Shaw R Gargis; Harry E Heath; Paul A LeBlanc; Linda Dekker; Robin S Simmonds; Gary L Sloan
Journal: Appl Environ Microbiol Date: 2010-08-20 Impact factor: 4.792

4. The molecular organization of the lysostaphin gene and its sequences repeated in tandem.

Authors: P Heinrich; R Rosenstein; M Böhmer; P Sonner; F Götz
Journal: Mol Gen Genet Date: 1987-10

5. Bacitracin: an inhibitor of the dephosphorylation of lipid pyrophosphate, an intermediate in the biosynthesis of the peptidoglycan of bacterial cell walls.

Authors: G Siewert; J L Strominger
Journal: Proc Natl Acad Sci U S A Date: 1967-03 Impact factor: 11.205

6. Hydrogen/deuterium exchange mass spectrometry and site-directed disulfide cross-linking suggest an important dynamic interface between the two lysostaphin domains.

Authors: Hai-Rong Lu; Mei-Gang Gu; Qiang Huang; Jin-jiang Huang; Wan-Ying Lu; Hong Lu; Qing-Shan Huang
Journal: Antimicrob Agents Chemother Date: 2013-02-04 Impact factor: 5.191

LYSOSTAPHIN: ENZYMATIC MODE OF ACTION.

1. Purification and partial characterization of a murein hydrolase, millericin B, produced by Streptococcus milleri NMSCC 061.

2. ABI domain-containing proteins contribute to surface protein display and cell division in Staphylococcus aureus.

3. Inhibition of the activity of both domains of lysostaphin through peptidoglycan modification by the lysostaphin immunity protein.

4. The molecular organization of the lysostaphin gene and its sequences repeated in tandem.

5. Bacitracin: an inhibitor of the dephosphorylation of lipid pyrophosphate, an intermediate in the biosynthesis of the peptidoglycan of bacterial cell walls.

6. Hydrogen/deuterium exchange mass spectrometry and site-directed disulfide cross-linking suggest an important dynamic interface between the two lysostaphin domains.

7. Comparison of various methods for differentiation of staphylococci and micrococci.

8. Use of resistant mutants to study the interaction of triton X-100 with Staphylococcus aureus.

9. Lysostaphin in experimental renal infections.

10. Bacteriolytic enzymes from Staphylococcus aureus. Specificity of ction of endo-beta-N-acetylglucosaminidase.